Trial of Olaparib in Combination With AZD5363 (ComPAKT)

NCT02338622 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Advanced Cancer

Interventions

DRUG: olaparib
DRUG: AZD5363

Sponsor

Royal Marsden NHS Foundation Trust

Collaborators

[object Object]
[object Object]